Publication dates

All regions

Anti Infective Industry, September 2014 Market Reports from Top Publishers

You might be interested in: medical equipment, therapeutics, contact lens, more »


 
1-20 of about 1 300 reports for Anti Infective

 Hospital Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections-Pipeline Insights, 2014

Hospital Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Hospital Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across ...

Torrent Pharmaceuticals Limited (TORNTPHARM) - Financial and Strategic SWOT Analysis Review

Torrent Pharmaceuticals Limited (TORNTPHARM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • August 2014
  • by Global Data

... Intestinal, diabetology, anti-infective, and pain management areas. It offers tablets, capsules, parenterals and active pharmaceutical ingredients (apis). The company's product portfolio includes insulin, lamotrigine ...

Northern Antibiotics Oy - Product Pipeline Review - 2014

Northern Antibiotics Oy - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • August 2014
  • by Global Markets Direct

Northern Antibiotics Oy - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Northern Antibiotics Oy - Product Pipeline Review - 2014', provides an overview of the Northern Antibiotics ...

PLIVA d.d. SWOT Analysis, Strategy, Revenues and Profits

PLIVA d.d. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

... The company offers wide variety of products including cardiovascular, gastrointestinal, anti-infectives, oncology, musculoskeletal, neurological and psychiatric diseases. The company's non-core businesses ...

Toyama Chemical Co., Ltd. - Strategic SWOT Analysis Review

Toyama Chemical Co., Ltd. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • August 2014
  • by Global Data

Summary Toyama Chemical Co., Ltd. (Toyama Chemical) is a pharmaceutical product manufacturer. It operates as a subsidiary of Fujifilm Holdings Corporation. The company develops, manufactures and sells ...

Creative Antibiotics Sweden AB - Strategic SWOT Analysis Review

Creative Antibiotics Sweden AB - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • August 2014
  • by Global Data

Summary This comprehensive SWOT profile of Creative Antibiotics Sweden AB provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clea ...

Sanofi India Limited (SANOFI) - Financial and Strategic SWOT Analysis Review

Sanofi India Limited (SANOFI) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • August 2014
  • by Global Data

... Manufacturing company. The company provides medicines for the treatment of patients with cardiovascular disease, thrombotic diseases, metabolic disorders, oncology, respiratory, dermatology, anti-infective ...

Camphor & Allied Products Ltd (500078) - Financial and Strategic SWOT Analysis Review

Camphor & Allied Products Ltd (500078) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • August 2014
  • by Global Data

Summary This comprehensive SWOT profile of Camphor & Allied Products Ltd provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

 Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections-Pipeline Insights, 2014

Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. ...

 Vancomycin-Resistant Enterococcus Faecium Infections-Pipeline Insights, 2014

Vancomycin-Resistant Enterococcus Faecium Infections-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Vancomycin-Resistant Enterococcus Faecium Infections-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ...

About 1 200 reports for Anti Infective

Download Unlimited Documents from Trusted Public Sources

Suzhou Dawnrays - Annual Report, March 2012

  • Corporate Presentation
  • March 2012
    72 pages
  • Drug  

    Anti-infective  

    Cephalosporin  

  • China  

    Asia  

View report >

4 Companies for Anti Infective

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Icon Group

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.